COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
Ankit Patel, Ashish Verma
Abstract
Matt Arentz, MD; Eric Yim, MD; Lindy Klaff, MD; Sharukh Lokhandwala, MD, MSc; Francis X. Riedo, MD; Maria Chong, MD; Melissa Lee, MD
Topics & Concepts
MedicineAngiotensin Receptor BlockersCoronavirus disease 2019 (COVID-19)Angiotensin-converting enzymePharmacologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Virology2019-20 coronavirus outbreakAngiotensin-converting enzyme 2Angiotensin IIEnzymeReceptorInternal medicineBiochemistryInfectious disease (medical specialty)DiseaseBlood pressureChemistryOutbreakCOVID-19 Clinical Research StudiesRenin-Angiotensin System StudiesVitamin C and Antioxidants Research